| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: Genentech/Roche |
| Recipient: Your Institution |
| Company: Lilly |
| Recipient: Your Institution |
| Company: Daiichi Sankyo |
| Recipient: Your Institution |
| Company: Mersana |
| Recipient: Your Institution |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
| Company: Stemline Therapeutics |
| Recipient: Your Institution |
| Company: Gilead Sciences |
| Recipient: Your Institution |
| Company: Jazz Pharmaceuticals |
| Recipient: Your Institution |
| Company: Jefferies |
| Recipient: Your Institution |
| Company: Tempus Labs |
| Recipient: Your Institution |
| Company: Arvinas |
| Recipient: Your Institution |
| Company: Circle Pharma |
| Recipient: Your Institution |
| Company: Janssen |
| Recipient: Your Institution |
| Company: Johnson and Johnson |
| Recipient: Your Institution |
| Company: Halda Therapeutics |
| Recipient: Your Institution |
| Company: Incyclix Bio |
| Recipient: Your Institution |
| Company: IQvia |
| Recipient: Your Institution |
| Company: Pyxis Oncology |
| Recipient: Your Institution |
| Company: Samsung Bioepis |
| Recipient: Your Institution |
| Company: Shorla Pharma |
| Recipient: Your Institution |
| Company: BeOne Medicines |
| Recipient: Your Institution |
| Company: BioNTech |
| Recipient: Your Institution |
| Company: Boehringer Ingelheim |
| Recipient: Your Institution |
| Company: Boundless Bio |
| Recipient: Your Institution |
| Company: Bristol-Myers Squibb |
| Recipient: Your Institution |
| Company: Precede Bio |
| Recipient: Your Institution |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Genentech/Roche |
| Recipient: Your Institution |
| Company: Verastem |
| Recipient: Your Institution |
| Company: Zymeworks |
| Recipient: Your Institution |
| Company: Rgenix |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
| Company: Mersana |
| Recipient: Your Institution |
| Company: Lilly |
| Recipient: Your Institution |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: Tesaro |
| Recipient: Your Institution |
| Company: H3 Biomedicine |
| Recipient: Your Institution |
| Company: Abbvie |
| Recipient: Your Institution |
| Company: Fujifilm |
| Recipient: Your Institution |
| Company: Regeneron |
| Recipient: Your Institution |
| Company: Taiho Pharmaceutical |
| Recipient: Your Institution |
| Company: Daiichi Sankyo |
| Recipient: Your Institution |
| Company: InventisBio |
| Recipient: Your Institution |
| Company: Sutro |
| Recipient: Your Institution |
| Company: Arvinas |
| Recipient: Your Institution |
| Company: Orinove |
| Recipient: Your Institution |
| Company: Seattle Genetics |
| Recipient: Your Institution |
| Company: Compugen |
| Recipient: Your Institution |
| Company: Shattuck Labs |
| Recipient: Your Institution |
| Company: Olema Pharmaceuticals |
| Recipient: Your Institution |
| Company: Immunogen |
| Recipient: Your Institution |
| Company: AtlasMedx |
| Recipient: Your Institution |
| Company: Ellipses Pharma |
| Recipient: Your Institution |
| Company: MabSpace Biosciences |
| Recipient: Your Institution |
| Company: Pionyr |
| Recipient: Your Institution |
| Company: Treadwell Therapeutics |
| Recipient: Your Institution |
| Company: Jacobio |
| Recipient: Your Institution |
| Company: Accutar Biotech |
| Recipient: Your Institution |
| Company: Artios |
| Recipient: Your Institution |
| Company: Dantari |
| Recipient: Your Institution |
| Company: Duality Biologics |
| Recipient: Your Institution |
| Company: Elucida Oncology |
| Recipient: Your Institution |
| Company: Relay Therapeutics |
| Recipient: Your Institution |
| Company: BeiGene |
| Recipient: Your Institution |
| Company: K-Group Beta |
| Recipient: Your Institution |
| Company: Kind Pharmaceuticals |
| Recipient: Your Institution |
| Company: Loxo Oncology |
| Recipient: Your Institution |
| Company: Orum Therapeutics |
| Recipient: Your Institution |
| Company: Prelude Therapeutics |
| Recipient: Your Institution |
| Company: Profound Bio |
| Recipient: Your Institution |
| Company: Cullinan Oncology |
| Recipient: Your Institution |
| Company: Gilead Sciences |
| Recipient: Your Institution |
| Company: Inspirna |
| Recipient: Your Institution |
| Company: Stemline Therapeutics |
| Recipient: Your Institution |
| Company: BeOne Medicines |
| Recipient: Your Institution |
| Company: Bicycle Therapeutics |
| Recipient: Your Institution |
| Company: Biohaven Pharmaceuticals |
| Recipient: Your Institution |
| Company: BioNTech |
| Recipient: Your Institution |
| Company: Day One Biopharmaceuticals |
| Recipient: Your Institution |
| Company: Exelixis |
| Recipient: Your Institution |
| Company: Genmab |
| Recipient: Your Institution |
| Company: Iambic Therapeutics |
| Recipient: Your Institution |
| Company: Jazz Pharmaceuticals |
| Recipient: Your Institution |
| Company: Mabwell Bioscience |
| Recipient: Your Institution |
| Company: Marengo Therapeutics |
| Recipient: Your Institution |
| Company: MediLink Therapeutics |
| Recipient: Your Institution |
| Company: Merck |
| Recipient: Your Institution |
| Company: Simcha Therapeutics |
| Recipient: Your Institution |
| Company: Systimmune |
| Recipient: Your Institution |
| Company: TheRas |
| Recipient: Your Institution |
| Company: Xadcera Biopharmaceutical |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|